Antineoplastic agents

Cell Line Origin Human Caucasian ovarian metastasis of a primary colon adenocarcinoma Cell Line Description Although originally thought to be of ovarian origin, a recent report has suggested that the SW 686 cell line might have been derived from an

Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details.

Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details.

Cell Line Origin Human ovarian adenocarcinoma (ascites) stage III Cell Line Description The OV17R cell line was derived from a human ovarian adenocarcinoma (ascites) stage III of a 50 year-old female. Culture Medium DMEM:HAMS F12 (1:1) + 2mM

Cell Line Origin Human ovarian cancer, stage III Cell Line Description The OV7 cell line was established from solid ovarian tumour tissue taken from a 78-year-old female patient. The tumour was characterised as stage III, mixed tumour type and

Cell Line Origin Human ovarian serous carcinoma (ascites) stage IV, poorly differentiated Cell Line Description The OV56 cell line was established from ascitic fluid derived from a 46-year-old female patient diagnosed with ovarian cancer. The

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the

Reduction of hydrocinnamoyl chloride at mercury cathodes in acetonitrile containing tetraalkylammonium perchlorates has been investigated by cyclic voltammetry . Application Hydrocinnamoyl chloride has been used in: enantioselective synthesis of

Reduction of hydrocinnamoyl chloride at mercury cathodes in acetonitrile containing tetraalkylammonium perchlorates has been investigated by cyclic voltammetry . Application Hydrocinnamoyl chloride has been used in: enantioselective synthesis of

Hydrogen hexahydroxyplatinate(IV)

Hydrogen hexahydroxyplatinate(IV)

Application This heterobifunctional, PEGylated crosslinker features a hydroxyl group at one end and t-butyl-protected carboxylic acid at the other, which can be deprotected with acidic conditions. The hydrophillic PEG linker facilitates solubility